Corona Remedies announces commencement of capacity expansion for commercial production at Bhayla facility: Our Bureau, Mumbai Monday, December 29, 2025, 13:30 Hrs [IST] Corona Rem ...
Biohaven’s phase 2 proof-of-concept study with BHV-7000 in major depressive disorder fails to meet its primary endpoint: New Haven, Connecticut Monday, December 29, 2025, 13:00 ...
Mumbai-based NMIMS Shobhaben Pratapbhai Patel School of Pharmacy gets 3 awards at 74th IPC: Our Bureau, Chennai Monday, December 29, 2025, 12:40 Hrs [IST] At the recent 74th India ...
Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
Caliway Biopharmaceuticals completes submission of IND application to US FDA for phase 2 study of CBL-514 for weight management: New Taipei City Monday, December 29, 2025, 11:00 H ...
IPC to host 36th Skill Development Programme on Pharmacovigilance from 9 to 13 March 2026: Shardul Nautiyal, Mumbai Monday, December 29, 2025, 09:00 Hrs [IST] The Indian Pharmacop ...
Australian health advisory on counterfeit Abhayrab is "over-cautionary" and "misplaced", says IIL: Our Bureau, New Delhi Monday, December 29, 2025, 10:00 Hrs [IST] Hyderabad-based ...
Panel asks Ministry of Ayush to improve support related to cultivation of medicinal plants: Gireesh Babu, New Delhi Monday, December 29, 2025, 08:00 Hrs [IST] The Parliamentary Pa ...
NPPA to allow Serum Institute to discontinue manufacturing of two pack sizes of TT vaccine: Gireesh Babu, New Delhi Monday, December 29, 2025, 08:00 Hrs [IST] The National Pharmac ...
Indian healthcare sector fuels rapid tech expansion with robust private capital infusion: Nandita Vijayasimha, Bengaluru Monday, December 29, 2025, 08:00 Hrs [IST] Indian healthca ...
Experts discuss Indian pharmaceutical strategic roadmap for 2026: Shardul Nautiyal, Mumbai Monday, December 29, 2025, 08:00 Hrs [IST] Indian pharmaceutical companies have a golden ...